Keywords: lilly, swings, 2nd-qtr, eps, drug, major, eli
Lilly swings to 2nd-qtr 2006 EPS of $0.76
Article | 31 July 2006
US drug major Eli Lilly reported second-quarter 2006 earnings of $822.0 million, or $0.76 per share, versus a loss of $252.0 million, or $0.23 per ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Is failure to adopt business process management putting the pharma industry at risk?
- New Zealand declines Alexion's funding application for Solaris
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
- Elan makes "transformational" acquisitions and a divestment
